Clearance of moxifloxacin during continuous haemofiltration (CVVHF) in vitro | Zendy

Karl Peter Ittner | Zendy; German A. Roth | Zendy; Michael Gruber | Zendy; Michael Pawlik | Zendy; K. Taeger | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clearance of moxifloxacin during continuous haemofiltration (CVVHF) in vitro

Author(s) -

Karl Peter Ittner,

German A. Roth,

Michael Gruber,

Michael Pawlik,

K. Taeger

Publication year - 2005

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dki205

Subject(s) - moxifloxacin , hemofiltration , renal function , albumin , chemistry , renal blood flow , medicine , chromatography , hemodialysis , endocrinology , biochemistry , antibiotics

The clearance of moxifloxacin is reported to be unaltered in the presence of renal insufficiency. There is little information about the clearance of intravenous moxifloxacin in renal replacement therapies during intensive care. The aim of this study was to determine the clearance of moxifloxacin during continuous veno-venous haemofiltration (CVVHF) in vitro.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research